Authors:
DEIRMENJIAN JM
ERHART SM
WIRSHING DA
SPELLBERG BJ
WIRSHING WC
Citation: Jm. Deirmenjian et al., OLANZAPINE-INDUCED REVERSIBLE PRIAPRISM - A CASE-REPORT, Journal of clinical psychopharmacology, 18(4), 1998, pp. 351-353
Authors:
ARAVAGIRI M
MARDER SR
WIRSHING D
WIRSHING WC
Citation: M. Aravagiri et al., PLASMA-CONCENTRATIONS OF RISPERIDONE AND ITS 9-HYDROXY METABOLITE ANDTHEIR RELATIONSHIP TO DOSE IN SCHIZOPHRENIC-PATIENTS - SIMULTANEOUS DETERMINATION BY A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Pharmacopsychiatry, 31(3), 1998, pp. 102-109
Citation: Wc. Wirshing, THE NEW ANTIPSYCHOTIC COMPOUNDS - IS A CLINICAL CHOICE ALGORITHM POSSIBLE, Western journal of medicine, 169(1), 1998, pp. 43-44
Authors:
KERN RS
GREEN MF
MARSHALL BD
WIRSHING WC
WIRSHING D
MCGURK S
MARDER SR
MINTZ J
Citation: Rs. Kern et al., RISPERIDONE VS. HALOPERIDOL ON REACTION-TIME, MANUAL DEXTERITY, AND MOTOR LEARNING IN TREATMENT-RESISTANT SCHIZOPHRENIA-PATIENTS, Biological psychiatry, 44(8), 1998, pp. 726-732
Authors:
UMBRICHT D
AMES D
WIRSHING WC
BAKER R
CHENGAPPA R
BORENSTEIN M
SCHOOLER N
MARDER S
KANE J
Citation: D. Umbricht et al., PREDICTORS OF RESPONSE TO CLOZAPINE IN A LONG-TERM DOUBLE-BLIND TREATMENT STUDY, Schizophrenia research, 24(1-2), 1997, pp. 189-189
Authors:
WIRSHING WC
BAKER R
UMBRICHT D
AMES D
SCHOOLER N
KANE J
MARDER SR
BORENSTEIN D
Citation: Wc. Wirshing et al., CLOZAPINE VS HALOPERIDOL - DRUG INTOLERANCE IN A CONTROLLED 6 MONTH TRIAL, Schizophrenia research, 24(1-2), 1997, pp. 268-268
Authors:
WIRSHING WC
AMES D
BISHEFF S
PIERRE JM
MENDOZA A
SUN A
Citation: Wc. Wirshing et al., HEPATIC-ENCEPHALOPATHY ASSOCIATED WITH COMBINED CLOZAPINE AND DIVALPROEX SODIUM TREATMENT, Journal of clinical psychopharmacology, 17(2), 1997, pp. 120-121
Citation: M. Aravagiri et al., PLASMA-LEVEL MONITORING OF OLANZAPINE IN PATIENTS WITH SCHIZOPHRENIA - DETERMINATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Therapeutic drug monitoring, 19(3), 1997, pp. 307-313
Authors:
AMES D
WIRSHING WC
BRAMMER G
PASHDAG J
YUWILER A
Citation: D. Ames et al., VARIABILITY IN WHOLE-BLOOD SEROTONIN AS A MARKER FOR SUICIDALITY IN SCHIZOPHRENIA, Biological psychiatry, 41, 1997, pp. 28-28
Authors:
GREEN MF
MARSHALL BD
WIRSHING WC
AMES D
MARDER SR
MCGURK S
KERN RS
MINTZ J
Citation: Mf. Green et al., DOES RISPERIDONE IMPROVE VERBAL WORKING-MEMORY IN TREATMENT-RESISTANTSCHIZOPHRENIA, The American journal of psychiatry, 154(6), 1997, pp. 799-804
Authors:
WIRSHING WC
AMES D
MARDER SR
MARSHALL BD
GREEN MF
MCGURK S
Citation: Wc. Wirshing et al., RISPERIDONE VS HALOPERIDOL IN TREATMENT-RESISTANT SCHIZOPHRENIA - PRELIMINARY-RESULTS, Schizophrenia research, 18(2-3), 1996, pp. 5-5
Authors:
AMES D
WIRSHING WC
BAKER RW
UMBRICHT DSG
SUN AB
CARTER J
SCHOOLER NR
KANE JM
MARDER SR
Citation: D. Ames et al., PREDICTIVE VALUE OF EOSINOPHILIA FOR NEUTROPENIA DURING CLOZAPINE TREATMENT, The Journal of clinical psychiatry, 57(12), 1996, pp. 579-581
Authors:
MCGURK SR
GREEN MF
WIRSHING WC
AMES D
MARSHALL BD
MARDER SR
Citation: Sr. Mcgurk et al., THE EFFECTS OF RISPERIDONE VS HALOPERIDOL ON SPATIAL WORKING-MEMORY IN TREATMENT-RESISTANT SCHIZOPHRENIA, Biological psychiatry, 39(7), 1996, pp. 245-245